Popping Stephanie, Bade Debora, Boucher Charles, van der Valk Mark, El-Sayed Manal, Sigurour Olafsson, Sypsa Vana, Morgan Timothy, Gamkrelidze Amiran, Mukabatsinda Constance, Deuffic-Burban Sylvie, Ninburg Michael, Feld Jordan, Hellard Margaret, Ward John
Department of Viroscience, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
Virology Education, Utrecht, the Netherlands.
J Virus Erad. 2019 Jan 1;5(1):60-66. doi: 10.1016/S2055-6640(20)30281-8.
Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and economic benefits and, most importantly, the prevention of 1.2 million deaths per year. In 2016, member states of the World Health Assembly unanimously adopted a resolution declaring that viral hepatitis should be eliminated by 2030. Currently, few countries have elimination programmes in place and even though the tools to achieve elimination are available, the right resources, commitments and allocations are lacking. During the fifth International Viral Hepatitis Elimination Meeting (IVHEM), 7-8 December 2018, Amsterdam, the Netherlands, an expert panel of clinicians, virologists and public health specialists discussed the current status of viral hepatitis elimination programmes across multiple countries, challenges in achieving elimination and the core indicators for monitoring progress, approaches that have failed and successful elimination plans.
全球范围内，乙肝病毒（HBV）和丙肝病毒（HCV）感染人数超过3.2亿，这比艾滋病毒、结核病和疟疾感染人数的总和还要多。因此，消除乙肝病毒和丙肝病毒将带来巨大的公共卫生和经济效益，最重要的是，每年可预防120万人死亡。2016年，世界卫生大会成员国一致通过一项决议，宣布到2030年消除病毒性肝炎。目前，很少有国家制定消除计划，而且尽管实现消除的工具已经具备，但仍缺乏适当的资源、承诺和拨款。在2018年12月7日至8日于荷兰阿姆斯特丹举行的第五届国际消除病毒性肝炎会议（IVHEM）上，由临床医生、病毒学家和公共卫生专家组成的专家小组讨论了多个国家消除病毒性肝炎计划的现状、实现消除的挑战以及监测进展的核心指标、失败的方法和成功的消除计划。
